AstraZeneca PLC is 222.3x more valuable than GH Research PLC by market capitalization ($286.27 B vs $1.29 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GHRS | AZN |
|---|---|---|
| Market cap | $1.29 B | $286.27 B |
| US-listed rank | #2450 | #45 |
| SEC filings | 186 | 1,004 |
AstraZeneca PLC is 222.3x more valuable than GH Research PLC by market capitalization ($286.27 B vs $1.29 B).
Full pages: GH Research PLC and AstraZeneca PLC, or browse the full rankings.